The ROE as of December 2025 (TTM) for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is 42.42%

According to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares’s latest financial reports and current stock price. The company's current ROE is 42.42%. This represents a change of Infinity% compared to the average of 0% of the last 4 quarters.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Historical ROE (quarterly & annually)

How has CUPR ROE performed in the past?

The mean historical ROE of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares over the last ten years is 52.80%. The current 42.42% ROE has changed -19.66% with respect to the historical average. Over the past ten years (40 quarters), CUPR's ROE was at its highest in in the December 2022 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at 0%.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) ROE by Quarter and Year

Discovering the peaks and valleys of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Average ROE

How has CUPR ROE performed in the past?

The current ROE of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) ROE vs. Peers

How is CUPR’s ROE compared to its peers?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares’s ROE is less than Curis, Inc. (354.21%), greater than Hoth Therapeutics, Inc. (-114.32%), greater than Processa Pharmaceuticals, Inc. (-342.35%), greater than Palisade Bio, Inc. (-240.71%), greater than BriaCell Therapeutics Corp. (-439.74%), greater than Curanex Pharmaceuticals Inc Common Stock (-33.34%), greater than Synlogic, Inc. (-26.47%), greater than Pulmatrix, Inc. (-94.13%), less than Aspire Biopharma Holdings, Inc. (388.20%), greater than Entero Therapeutics, Inc. (-31.69%),

Build a custom stock screener for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cuprina Holdings (Cayman) Limited Class A Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cuprina Holdings (Cayman) Limited Class A Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.